These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 9607078

  • 1. Cross-protection of mice immunized with different influenza A (H2) strains and challenged with viruses of the same HA subtype.
    Govorkova EA, Smirnov YuA.
    Acta Virol; 1997 Oct; 41(5):251-7. PubMed ID: 9607078
    [Abstract] [Full Text] [Related]

  • 2. Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit.
    Tamura S, Ito Y, Asanuma H, Hirabayashi Y, Suzuki Y, Nagamine T, Aizawa C, Kurata T.
    J Immunol; 1992 Aug 01; 149(3):981-8. PubMed ID: 1634780
    [Abstract] [Full Text] [Related]

  • 3. A protective immune response in mice to viral components other than hemagglutinin in a live influenza A virus vaccine model.
    Horimoto T, Takada A, Iwatsuki-Horimoto K, Kawaoka Y.
    Vaccine; 2004 Jun 02; 22(17-18):2244-7. PubMed ID: 15149783
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines.
    Tamura S, Tanimoto T, Kurata T.
    Jpn J Infect Dis; 2005 Aug 02; 58(4):195-207. PubMed ID: 16116250
    [Abstract] [Full Text] [Related]

  • 5. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
    Du N, Li W, Li Y, Liu S, Sui Y, Qu Z, Wang Y, Du Y, Xu B.
    Vaccine; 2008 Jun 02; 26(23):2912-8. PubMed ID: 18448208
    [Abstract] [Full Text] [Related]

  • 6. Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice.
    Qiu M, Fang F, Chen Y, Wang H, Chen Q, Chang H, Wang F, Wang H, Zhang R, Chen Z.
    Biochem Biophys Res Commun; 2006 May 19; 343(4):1124-31. PubMed ID: 16580631
    [Abstract] [Full Text] [Related]

  • 7. Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans.
    Sandbulte MR, Jimenez GS, Boon AC, Smith LR, Treanor JJ, Webby RJ.
    PLoS Med; 2007 Feb 19; 4(2):e59. PubMed ID: 17298168
    [Abstract] [Full Text] [Related]

  • 8. Cross-protection and reassortment studies with avian H2 influenza viruses.
    Kaverin NV, Smirnov YA, Govorkova EA, Rudneva IA, Gitelman AK, Lipatov AS, Varich NL, Yamnikova SS, Makarova NV, Webster RG, Lvov DK.
    Arch Virol; 2000 Feb 19; 145(6):1059-66. PubMed ID: 10948982
    [Abstract] [Full Text] [Related]

  • 9. Studies on the usefulness of intranasal inactivated influenza vaccines.
    Tamura S.
    Vaccine; 2010 Aug 31; 28(38):6393-7. PubMed ID: 20493820
    [Abstract] [Full Text] [Related]

  • 10. Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.
    Sambhara S, Kurichh A, Miranda R, Tumpey T, Rowe T, Renshaw M, Arpino R, Tamane A, Kandil A, James O, Underdown B, Klein M, Katz J, Burt D.
    Cell Immunol; 2001 Aug 01; 211(2):143-53. PubMed ID: 11591118
    [Abstract] [Full Text] [Related]

  • 11. Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses.
    Lu X, Edwards LE, Desheva JA, Nguyen DC, Rekstin A, Stephenson I, Szretter K, Cox NJ, Rudenko LG, Klimov A, Katz JM.
    Vaccine; 2006 Nov 10; 24(44-46):6588-93. PubMed ID: 17030078
    [Abstract] [Full Text] [Related]

  • 12. Inactivated influenza H5N1 whole-virus vaccine with aluminum adjuvant induces homologous and heterologous protective immunities against lethal challenge with highly pathogenic H5N1 avian influenza viruses in a mouse model.
    Ninomiya A, Imai M, Tashiro M, Odagiri T.
    Vaccine; 2007 May 04; 25(18):3554-60. PubMed ID: 17293015
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques.
    Itoh Y, Ozaki H, Tsuchiya H, Okamoto K, Torii R, Sakoda Y, Kawaoka Y, Ogasawara K, Kida H.
    Vaccine; 2008 Jan 24; 26(4):562-72. PubMed ID: 18164788
    [Abstract] [Full Text] [Related]

  • 15. Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine.
    Vincent AL, Lager KM, Janke BH, Gramer MR, Richt JA.
    Vet Microbiol; 2008 Jan 25; 126(4):310-23. PubMed ID: 17719188
    [Abstract] [Full Text] [Related]

  • 16. A live attenuated H1N1 M1 mutant provides broad cross-protection against influenza A viruses, including highly pathogenic A/Vietnam/1203/2004, in mice.
    Xie H, Liu TM, Lu X, Wu Z, Belser JA, Katz JM, Tumpey TM, Ye Z.
    J Infect Dis; 2009 Dec 15; 200(12):1874-83. PubMed ID: 19909080
    [Abstract] [Full Text] [Related]

  • 17. Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.
    Altstein AD, Gitelman AK, Smirnov YA, Piskareva LM, Zakharova LG, Pashvykina GV, Shmarov MM, Zhirnov OP, Varich NP, Ilyinskii PO, Shneider AM.
    Arch Virol; 2006 May 15; 151(5):921-31. PubMed ID: 16292596
    [Abstract] [Full Text] [Related]

  • 18. Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus.
    Asahi-Ozaki Y, Yoshikawa T, Iwakura Y, Suzuki Y, Tamura S, Kurata T, Sata T.
    J Med Virol; 2004 Oct 15; 74(2):328-35. PubMed ID: 15332283
    [Abstract] [Full Text] [Related]

  • 19. Differences between original strains and their mouse-adapted variants of human (H1) and avian (H2) influenza A viruses in the reaction with cross-neutralizing monoclonal antibody recognizing conformational epitope.
    Lipatov AS, Gitelman AK, Smirnov YuA.
    Acta Virol; 1996 Sep 15; 40(4):227-30. PubMed ID: 9014015
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.